{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:15:49Z","timestamp":1788952549419,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T00:00:00Z","timestamp":1701820800000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pbb.2022.173496","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:16:32Z","timestamp":1669295792000},"page":"173496","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Structurally diverse fentanyl analogs yield differential locomotor activities in mice"],"prefix":"10.1016","volume":"222","author":[{"given":"Neil B.","family":"Varshneya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Matthew","family":"Walentiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teneille D.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luli R.","family":"Akinfiresoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Beardsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pbb.2022.173496_bb0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.pbb.2022.173496_bb0010","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/dta.2326","article-title":"Fatality involving ocfentanil documented by identification of metabolites","volume":"10","author":"Allibe","year":"2018","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.pbb.2022.173496_bb0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.01.004","article-title":"Characterizing fentanyl use in methadone-maintained clients","volume":"75","author":"Arfken","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"issue":"1","key":"10.1016\/j.pbb.2022.173496_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1213\/00000539-198501000-00010","article-title":"Anesthetic induction with fentanyl","volume":"64","author":"Bailey","year":"1985","journal-title":"Anesth. Analg."},{"issue":"12","key":"10.1016\/j.pbb.2022.173496_bb0025","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1007\/s00213-021-05981-x","article-title":"Pharmacokinetics and pharmacodynamics of cyclopropylfentanyl in male rats","volume":"238","author":"Bergh","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"10.1016\/j.pbb.2022.173496_bb0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jat\/bkaa115","article-title":"A 2017\u20132019 update on acute intoxications and fatalities from illicit fentanyl and analogs","volume":"45","author":"Brunetti","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pbb.2022.173496_bb0035","series-title":"Dataare From the Multiple Cause of Death Files, 1999-2020, as Compiled From DataProvided by the 57 Vital Statistics Jurisdictions Through the Vital StatisticsCooperative Program","article-title":"Multiple cause of death 1999-2019 on CDC WONDER online database, released in 2021","year":"2021"},{"key":"10.1016\/j.pbb.2022.173496_bb0040","first-page":"1","article-title":"A cross-sectional analysis of fentanyl analog exposures among living patients","author":"Chhabra","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2022.173496_bb0045","series-title":"StatisticalPower Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pbb.2022.173496_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2022.173496_bb0055","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.pbb.2022.173496_bb0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.forsciint.2016.07.005","article-title":"Ocfentanil overdose fatality in the recreational drug scene","volume":"266","author":"Coopman","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.pbb.2022.173496_bb0065","series-title":"DEA Intelligence Brief","article-title":"Counterfeit prescription pills containing fentanyls: a global threat","year":"2016"},{"key":"10.1016\/j.pbb.2022.173496_bb0070","series-title":"NFLIS Brief: Fentanyl and Fentanyl-Related Substances Reported in NFLIS, 2015\u20132016","year":"2017"},{"key":"10.1016\/j.pbb.2022.173496_bb0075","series-title":"NFLIS Brief: Fentanyl, 2001\u20132015","article-title":"NFLIS brief: fentanyl, 2001\u20132015","volume":"March 2017","year":"2017"},{"key":"10.1016\/j.pbb.2022.173496_bb0080","series-title":"NFLIS-DRUG 2019 Annual Report","year":"2020"},{"key":"10.1016\/j.pbb.2022.173496_bb0085","series-title":"Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-related Substances in Schedule I, Docket No. DEA\u2013476","year":"2021"},{"key":"10.1016\/j.pbb.2022.173496_bb0090","series-title":"Schedules of Controlled Substances: Placement of Four Specific Fentanyl-related Substances in Schedule I, Docket No. DEA\u2013806","year":"2021"},{"key":"10.1016\/j.pbb.2022.173496_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2022.173496_bb0100","series-title":"European Drug Report 2018: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"issue":"2","key":"10.1016\/j.pbb.2022.173496_bb0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"4","key":"10.1016\/j.pbb.2022.173496_bb0110","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"issue":"8","key":"10.1016\/j.pbb.2022.173496_bb0115","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/dta.2822","article-title":"In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis","volume":"12","author":"Hassanien","year":"2020","journal-title":"Drug Test Anal."},{"key":"10.1016\/j.pbb.2022.173496_bb0120","series-title":"National Vital Statistics Reports","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016","author":"Hedegaard","year":"2018"},{"key":"10.1016\/j.pbb.2022.173496_bb0125","series-title":"National Vital Statistics Reports","article-title":"Regional differences in the drugs most frequently involved in drug overdose deaths: United States, 2017","author":"Hedegaard","year":"2019"},{"key":"10.1016\/j.pbb.2022.173496_bb0130","series-title":"N-(1-Arylalkyl-4-piperidyl)-Narylamide, deren Saureadditionssalze und Verfahren zu ihrer Herstellung","author":"Janssen","year":"1975"},{"key":"10.1016\/j.pbb.2022.173496_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","article-title":"Expected and actual fentanyl exposure among persons seeking opioid withdrawal management","volume":"86","author":"Kenney","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.pbb.2022.173496_bb0140","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","article-title":"Abuse of fentanyl: an emerging problem to face","volume":"289","author":"Kuczynska","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.pbb.2022.173496_bb0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/27.7.499","article-title":"Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases","volume":"27","author":"Kuhlman","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.pbb.2022.173496_bb0150","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jat\/30.8.603","article-title":"Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002\u20132004)","volume":"30","author":"Martin","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2022.173496_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ajad.13092","article-title":"The increasing prevalence of fentanyl: a urinalysis-based study among individuals with opioid use disorder in New York City","volume":"30","author":"Martinez","year":"2021","journal-title":"Am. J. Addict."},{"issue":"5","key":"10.1016\/j.pbb.2022.173496_bb0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2165\/00003088-198308050-00004","article-title":"Clinical pharmacokinetics of fentanyl and its newer derivatives","volume":"8","author":"Mather","year":"1983","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.pbb.2022.173496_bb0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2018.10.007","article-title":"Fentanyl exposure among patients seeking opioid treatment","volume":"96","author":"Ochalek","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"16","key":"10.1016\/j.pbb.2022.173496_bb0170","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.pbb.2022.173496_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"issue":"2","key":"10.1016\/j.pbb.2022.173496_bb0180","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00000542-199902000-00034","article-title":"A review of the use of fentanyl analgesia in the management of acute pain in adults","volume":"90","author":"Peng","year":"1999","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.pbb.2022.173496_bb0185","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/2042098617744161","article-title":"Naloxone dosage for opioid reversal: current evidence and clinical implications","volume":"9","author":"Rzasa Lynn","year":"2018","journal-title":"Ther. Adv. Drug Saf."},{"issue":"1","key":"10.1016\/j.pbb.2022.173496_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1124\/jpet.121.001045","article-title":"Role of efficacy as a determinant of locomotor activation by mu opioid receptor ligands in female and male mice","volume":"382","author":"Santos","year":"2022","journal-title":"J Pharmacol Exp Ther."},{"issue":"4","key":"10.1016\/j.pbb.2022.173496_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2165\/00003088-199631040-00004","article-title":"Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update","volume":"31","author":"Scholz","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.pbb.2022.173496_bb0200","series-title":"National Vital Statistics Reports","article-title":"Drug overdose deaths involving fentanyl, 2011\u20132016","author":"Spencer","year":"2019"},{"issue":"4","key":"10.1016\/j.pbb.2022.173496_bb0205","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1556-4029.2007.00481.x","article-title":"Fentanyl concentrations in 23 postmortem cases from the hennepin county medical examiner's office","volume":"52","author":"Thompson","year":"2007","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.pbb.2022.173496_bb0210","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2019.03.023","article-title":"Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances","volume":"151","author":"Varshneya","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2022.173496_bb0215","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2021","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pbb.2022.173496_bb0220","article-title":"Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors","volume":"173242","author":"Varshneya","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2022.173496_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114805","article-title":"Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated","volume":"195","author":"Varshneya","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2022.173496_bb0230","article-title":"Opioid use disorder treatment in the fentanyl era","author":"Varshneya","year":"2022","journal-title":"J Addict Med."},{"key":"10.1016\/j.pbb.2022.173496_bb0235","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.drugalcdep.2018.02.035","article-title":"Nociceptin\/orphanin FQ receptors modulate the discriminative stimulus effects of oxycodone in C57BL\/6 mice","volume":"187","author":"Walentiny","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2022.173496_bb0240","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neuropharm.2019.02.007","article-title":"Oxycodone-like discriminative stimulus effects of fentanyl-related emerging drugs of abuse in mice","volume":"150","author":"Walentiny","year":"2019","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305722001757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305722001757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:43:46Z","timestamp":1758775426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305722001757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":48,"alternative-id":["S0091305722001757"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2022.173496","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structurally diverse fentanyl analogs yield differential locomotor activities in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2022.173496","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"173496"}}